KAdd image
KPV
HealingSingleAlso known as: Lysine-Proline-Valine, α-MSH tripeptide
A small tripeptide derived from the C-terminus of α-melanocyte-stimulating hormone, studied for anti-inflammatory effects in skin and gut.
Half-life
1 h
Common dose
200 – 500 mcg
Dosing frequency
Daily
Administration
Subcutaneous, Oral
How it works
KPV downregulates pro-inflammatory cytokine production (TNF-α, IL-1β) and modulates NF-κB signaling. It has shown benefit in models of colitis, atopic dermatitis, and acne by reducing local inflammation without systemic immune suppression.
Protocol notes
Subcutaneous protocols typically use 200–500 mcg daily for 4–8 weeks for inflammatory conditions. Oral capsule forms exist for gut-targeted use. Often stacked with BPC-157 for gastrointestinal repair protocols.
Reported side effects
Very well-tolerated in research literature. Mild injection-site reactions are the most commonly reported.